CMECME Group

$280.55+11% 1Y

$280.55

$231.6852 weeks$317.19

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 23.8 vs a 21.6 median over 41 quarters (+10% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

CME Group trades at 23.8× earnings against 23.8× for the median Financial Data & Stock Exchanges name, more expensive than its own group.

23.8

Trailing P/E · Financial Data & Stock Exchanges median 23.8 · 1.00× the median: the market pays up for this one

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $11.79 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$231.68
Its own P/E history, median	$255.01
Its own P/E history, upper quartile	$295.58
52-week range	$231.68 – $317.19
Today	$280.55

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Ranks #27 of 66 by RyuScore